Veritas Buys Curoverse to Bring A.I. Analysis of Genes to the Masses

August 03, 2017 | Some answers to questions about the risk of developing a disease or a bad reaction to a drug can be found by analyzing a patient's genes. In the not-too-distant future, such queries could be as easy as searching for and selecting a movie on Netflix, contends Rodrigo Martinez, chief marketing and design officer for Veritas Genetics. Xconomy